NCT06141317View on ClinicalTrials.gov

Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 23, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

November 1, 2024

Conditions
Parkinson Disease
Interventions
BIOLOGICAL

PASC transplantation (25 million PASCs/patient)

3 doses of 25 million PASCs implantation via peripheral vein (Day 0, 3 months, 6 months)

BIOLOGICAL

Control

0.9% saline solution via peripheral vein (Day 0, 3 months, 6 months)

Trial Locations (2)

10801

Hospital Clínica Católica, San José

Unknown

Clínica NeuroFT, San José

All Listed Sponsors
collaborator

Universidad de Costa Rica

OTHER

collaborator

University of California, Los Angeles

OTHER

lead

ClusterXStem-Costa Rica

OTHER